[go: up one dir, main page]

SE9700203D0 - (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1-yl)fenoxi)smörsyra som cellulär adhesionsinhibitor - Google Patents

(-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1-yl)fenoxi)smörsyra som cellulär adhesionsinhibitor

Info

Publication number
SE9700203D0
SE9700203D0 SE9700203A SE9700203A SE9700203D0 SE 9700203 D0 SE9700203 D0 SE 9700203D0 SE 9700203 A SE9700203 A SE 9700203A SE 9700203 A SE9700203 A SE 9700203A SE 9700203 D0 SE9700203 D0 SE 9700203D0
Authority
SE
Sweden
Prior art keywords
pyridyl
methyl
butyric acid
phenoxy
cellular adhesion
Prior art date
Application number
SE9700203A
Other languages
English (en)
Other versions
SE9700203L (sv
SE510812C2 (sv
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of SE9700203D0 publication Critical patent/SE9700203D0/sv
Publication of SE9700203L publication Critical patent/SE9700203L/sv
Publication of SE510812C2 publication Critical patent/SE510812C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9700203A 1995-06-01 1997-01-24 (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitor SE510812C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
PCT/GB1996/001260 WO1996038416A1 (en) 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Publications (3)

Publication Number Publication Date
SE9700203D0 true SE9700203D0 (sv) 1997-01-24
SE9700203L SE9700203L (sv) 1997-01-24
SE510812C2 SE510812C2 (sv) 1999-06-28

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700203A SE510812C2 (sv) 1995-06-01 1997-01-24 (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitor

Country Status (31)

Country Link
EP (1) EP0796247A1 (sv)
JP (1) JP2885941B2 (sv)
KR (1) KR100245957B1 (sv)
AT (1) AT406675B (sv)
AU (1) AU710105B2 (sv)
BE (1) BE1009520A5 (sv)
BR (1) BR9606409A (sv)
CA (1) CA2194397A1 (sv)
CH (1) CH691808A5 (sv)
CZ (1) CZ26997A3 (sv)
DE (1) DE19680509T1 (sv)
DK (1) DK10697A (sv)
ES (1) ES2137886B1 (sv)
FI (1) FI970393A7 (sv)
GB (1) GB2304340B (sv)
GR (1) GR1002702B (sv)
HU (1) HUP9700274A3 (sv)
IE (1) IE960405A1 (sv)
IL (1) IL118477A0 (sv)
IT (1) IT1290839B1 (sv)
LU (1) LU90008B1 (sv)
MC (1) MC2418A1 (sv)
MX (1) MX9700379A (sv)
NL (1) NL1003243C2 (sv)
NO (1) NO307460B1 (sv)
NZ (1) NZ308597A (sv)
PL (1) PL318440A1 (sv)
SE (1) SE510812C2 (sv)
SK (1) SK13097A3 (sv)
TR (1) TR199700020T1 (sv)
WO (1) WO1996038416A1 (sv)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
JP3088016B2 (ja) * 1993-03-29 2000-09-18 ゼネカ・リミテッド 血小板凝集抑制剤としての複素環式化合物
PL310889A1 (en) * 1993-03-29 1996-01-08 Zeneca Ltd Heterocyclic derivatives as inhibitors of thrombocytes aggregation

Also Published As

Publication number Publication date
FI970393L (sv) 1997-01-30
FI970393A0 (sv) 1997-01-30
CZ26997A3 (en) 1997-08-13
AU710105B2 (en) 1999-09-16
DK10697A (da) 1997-04-01
CA2194397A1 (en) 1996-12-05
LU90008B1 (fr) 1997-04-16
NZ308597A (en) 1998-11-25
NO970437D0 (no) 1997-01-31
HUP9700274A2 (hu) 1999-06-28
AT406675B (de) 2000-07-25
JP2885941B2 (ja) 1999-04-26
DE19680509T1 (de) 1997-12-04
GB2304340B (en) 1998-07-29
ITMI961113A0 (it) 1996-05-31
SE9700203L (sv) 1997-01-24
ES2137886B1 (es) 2000-08-16
BE1009520A5 (fr) 1997-04-01
TR199700020T1 (tr) 1997-04-22
WO1996038416A1 (en) 1996-12-05
AU5827296A (en) 1996-12-18
SK13097A3 (en) 1997-08-06
MC2418A1 (fr) 1997-05-23
JPH09512836A (ja) 1997-12-22
MX9700379A (es) 1997-04-30
GB9627127D0 (en) 1997-02-19
HUP9700274A3 (en) 2000-02-28
NO970437L (no) 1997-02-20
FI970393A7 (sv) 1997-01-30
IT1290839B1 (it) 1998-12-14
GB2304340A (en) 1997-03-19
SE510812C2 (sv) 1999-06-28
GR1002702B (el) 1997-05-22
EP0796247A1 (en) 1997-09-24
NO307460B1 (no) 2000-04-10
HU9700274D0 (en) 1997-04-28
CH691808A5 (de) 2001-10-31
ATA900596A (de) 1999-12-15
ITMI961113A1 (it) 1997-12-01
IL118477A0 (en) 1996-09-12
IE960405A1 (en) 1996-12-11
BR9606409A (pt) 1997-09-30
KR100245957B1 (ko) 2000-04-01
KR970704689A (ko) 1997-09-06
ES2137886A1 (es) 1999-12-16
PL318440A1 (en) 1997-06-09
NL1003243C2 (nl) 1996-12-04

Similar Documents

Publication Publication Date Title
NO955256L (no) Fenylheterosykluser som syklooksygenase-2-inhibitorer
DK0863891T3 (da) (Methylsulfonyl)phenyl-2-(5H)-furanoner som COX2-inhibitorer
FI971412A0 (sv) Peptidylföreningar och deras terapeutisk användning som inhibitorer av metalloproteas
SE8700498D0 (sv) Novel pharmaceologically active compounds
NO914092L (no) Nye mercaptoacetylamid-derivater som er anvendbare som inhibitorer for enkefalinase og ace
IS4326A (is) Ný forðakyrni og lyfjablanda sem inniheldur þau
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
FI943728A0 (sv) Nya aminoacetylmerkatoderivat användbara som enkefalinas- och ACE-inhibitorer
NO963370L (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
DE69618820D1 (de) 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren
BR0009244A (pt) Inibidores de metaloprotease di-hétero substituìdos
BR0111678A (pt) Composições medicinais contendo derivados de propenona
FI913556A0 (fi) Nya piperidyletrar och -tioetrar som inhibitorer av kolesterolbiosyntes.
DK67682A (da) Fremgangsmaade til fremstilling af substituerede 3-aminosydnoniminer eller syreadditionssalte deraf samt disse forbindelsers anvendelse mod cardiovaskulaere sygdomme
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
NO982072D0 (no) Amidin- og isotioureaderivater som inhibitorer av nitrogenoksydsyntase
SE9700203D0 (sv) (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1-yl)fenoxi)smörsyra som cellulär adhesionsinhibitor
NO963369D0 (no) Nye indan-2-mercaptoacetylamid-disulfidderivater som er anvendbare som inhibitorer av enkefalinase
DK164159C (da) Oeoeoe(3-pyridinyl)methylenaaaminoaaoxyaaalkansyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
BR0014759A (pt) Inibidores de metaloprotease beta dissubstituìdos
AU7470098A (en) Antithrombotic agents
HRP20050815A2 (en) 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
RU94028126A (ru) Средство, обладающее иммуномодулирующей активностью
DE69925301D1 (de) Zusammensetzung von riluzol und alpha-tocopherol

Legal Events

Date Code Title Description
NUG Patent has lapsed